NUH Medicines Policy: Code of Practice

Size: px
Start display at page:

Download "NUH Medicines Policy: Code of Practice"

Transcription

1 NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST NUH Medicines Policy: Code of Practice THE USE OF SYRINGES TO ADMINISTER FLUSHES, FEEDS AND MEDICATION VIA THE ORAL AND ENTERAL ROUTES POLICY Reference CL/MM/037 Approving Body Senior Management Team Date Approved 23 November 2016 Implementation Date 23 November 2016 Version 1 (supersedes version 3 of CL/CGP/016 and version 2 of CL/CGP/069) Summary of Changes from Change to make reference to new ISO Previous Version connector (ISO ENFit) for enteral feeding tubes. Change to specify the use of ENFit compatible equipment including bottle adaptors to withdraw liquid medicines from medicine bottles. Change to use bottle adaptor /enteral syringe system to measure all doses of liquid medicines. Amalgamation of 2 previous policies, and move to include this policy as part of the overall NUH medicines policy Supersedes CL/CGP/016 version 3: The Use Of Syringes To Administer Flushes, Feeds And Medication Via The Oral And Enteral Routes In Adults Policy Consultation Undertaken CL/CGP/069 version 2: The Use of Syringes to Administer Flushes, Feeds and Medication via the Oral and Enteral Routes in Children/ Young People And Neonates Policy Adult Nutrition Nurse Specialist Children s gastrostomy and stoma Nurse Digestive Diseases & Thoracics Lead The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

2 Pharmacist Paediatric Pharmacist Neonatal Pharmacist Paediatric Dietitian Practice Development Matron Children s Services Children s Nurse Specialist Neonatal Nurse Critical Care Governance Matron Clinical Procurement Matron Medical Devices Clinical Lead Medicines Safety Group (Sept 2016) Medicines Management Committee (Oct 16) Medical Devices Safety Officer (Sept 2016) Dietetics Medicines Safety Officer Date of Completion of Equality Impact Assessment Date of Completion of We Are Here for You Assessment Date of Environmental Impact Assessment (if applicable) Legal and/or Accreditation Implications 02/10/16 02/10/16 02/10/16 This policy must be in place to fulfil requirements of NPSA alert no 19 Promoting safer measurement and administration of liquid medicines via oral and other enteral routes, 28 th March 2007 and to prevent wrong route Never Events. The Department of Health Never Events list includes: Wrong route administration of medication; Oral/enteral medication or feed/flush administered by any parenteral route Target Audience All NUH staff who prescribe, supply and administer oral liquid medicines. All NUH staff involved in the process of The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

3 prescribing, supply and administration of feeds and flushes by the enteral route. Review Date Nov 2019 Lead Director Medical Director Author/Lead Manager Further Guidance/Information Rachel Medcalf Medicines Safety Officer Ext Medicines Management Committee secretary Ext Adult Nutrition Nurse Specialist (NCH) Ext Digestive Diseases & Thoracics Lead Pharmacist Pharmacist, Ext Bleep Children s Gastrostomy Nurse, Ext Paediatric Lead pharmacist, Ext Bleep Children s Dietitian, Ext Neonatal Clinical Development Nurse, Ext Clinical Procurement Specialist (QMC) Ext Medicines Safety officer ext The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

4 CONTENTS Paragraph Title Page 1. Introduction 5 2. Executive Summary 5 3. Policy Statement 6 4. Definitions (including Glossary as needed) 7 5. Roles and Responsibilities 8 6. Policy and/or Procedural Requirements 9 7. Training, Implementation and Resources Impact Assessments Monitoring Matrix Relevant Legislation, National Guidance 16 and Associated NUH Documents 11. References 17 Appendix 1 Procedure for the use of ENFit compatible enteral syringes to administer liquid medicines via the ORAL route IN ADULTS 18 Appendix 2 Appendix 3 Procedure for the use of ENFit compatible syringes to measure and administer feeds, flushes and liquid medicines via the ENTERAL route IN ADULTS Procedure for the use of oral / enteral ENFit syringes to administer liquid medicines or feeds via the ORAL/ENTERAL ROUTE in CHILDREN Appendix 4 Equality Impact Assessment 64 Appendix 5 Environmental Impact Assessment 67 Appendix 6 Here For You Assessment 69 Appendix 7 Certification Of Employee Awareness 71 The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

5 1.0 Introduction 1.1 Wrong route administration of oral medicines, flushes or enteral feeds can cause serious patient harm and may even be fatal. This policy states the practice required at NUH to reduce the risks of wrong route administration associated with the use of syringes for the administration of medication, feeds and flushes via the oral or enteral routes at NUH. 2.0 Executive Summary 2.1 In 2007 the National Patient Safety Agency issued a patient safety alert; Promoting safer measurement and administration of liquid medicines via oral and other enteral routes (1).The alert aimed to reduce the risk of wrong route administration errors with oral medicines and enteral feeds. The alert stated a requirement for the use of oral/enteral syringes and specified the design of enteral feeding systems to prevent wrong route errors. In 2012 the Department of Health issued a list of Never Events. Never Events are serious incidents that are wholly preventable, as guidance or safety recommendations that provide strong systemic protective barriers, are available at a national level and should have been implemented by all healthcare providers (2). Administration of oral medicines or feeds/flushes by the parenteral route is a Never Event. There have been wrong route Never Events at NUH due to parenteral administration of medication intended for oral or enteral administration (3). This policy incorporates the requirements of the legacy NPSA alert, the current NHS England Never Events List and the recommendations from the NUH serious incident investigations. It sets out the actions required to reduce the risks of wrong route administration of oral medicines and enteral feeds/flushes at NUH. Oral and enteral ENFit compatible syringes must be used to measure liquid medicines, feeds and enteral flushes. Parenteral (Hypodermic) syringes must NEVER be used for this purpose. ENFit compatible bottle adaptors or ENFit compatible straws The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

6 must be used with an ENFit compatible oral/enteral syringe to withdraw liquid medicines from medicine bottles. 3 way taps must not be used for enteral feeding systems. Adaptors which enable oral/enteral syringes to fit intravenous ports must not be used. Enteral feeding tubes and administration/extension sets must not contain ports nor have end connectors that can be connected to intravenous syringes or parenteral lines. Medication prescribed for enteral administration must be rationalised to the least number without compromising patient care. Preparation and administration via the enteral or oral route should be separated from any parenteral route preparation or administration. ENFit oral/enteral syringes used for oral administration or measuring liquid medicines for enteral administration must be single use only. Large ENFit enteral syringes used for enteral administration must be single use per patient episode of care. The nurse who prepares the medication must be the nurse who administers the medication to the patient. All enteral feeding sets and syringes must be clearly labelled enteral. 3.0 Policy Statement 3.1 The Trust supports the use of ENFit compatible syringes and enteral feeding systems to reduce the risk of wrong route administration of oral medicines, feeds and enteral flushes. This policy and the associated standard operating procedures, apply to all practitioners working at NUH or working in affiliated hospitals or in the community on behalf of NUH, who are involved in prescribing, supply and administering oral liquid medicines. This policy and the associated standard operating procedures, apply to all practitioners working at NUH or working in affiliated hospitals or in the community on behalf of NUH, who are involved in prescribing, supply and administering feeds and flushes by the enteral route. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

7 When practitioners employed by other Trusts or private companies are contracted to practice in NUH they must comply with all NUH policies, procedures and guidelines for medicines. 4.0 Definitions 4.1 ISO: The International Standards Organisation ENFit: a global connector design that complies with ISO while also defining the orientation of the connectors within the enteral feeding system (female on the administration device and male on the receiving device). Oral administration: administered via the mouth Enteral administration: method of delivery where fluid is administered directly into the gastrointestinal tract Enteral/ oral syringe: An ISO ENFit compatible syringe, labelled ENTERAL with purple plunger, used to administer medication via the mouth OR administer medication, feeds or flushes via an Enteral Feeding Device. Enteral Feeding Device: Naso-gastric tube Naso-jejunal tube Gastrostomy tubes (PEG, RIG, Balloon) Gastrostomy button Replacement gastrostomy tube Gastro-Jejunal tubes(pegj, PEJ) Jejunal tubes Jejunostomy tube Malecot catheter & Foley catheter (Neonates only) Single Use: Use once and dispose of immediately Patient episode of care: a set of drug or feed administrations & The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

8 flushes at a given administration time for an individual patient. Bottle Adaptor: a plastic insert which fits within the neck of a medicine bottle to prevent drawing up of liquid medicine into any syringe other than an ENFit compatible enteral/oral Syringe. Filter straw: an ENFit compatible filter straw to allow drawing up of medicines into an ENFIT compatible enteral/oral syringe. Blunt needle: an ENFit compatible blunt needle. 5.0 Roles and Responsibilities 5.1 Committees The Medicines Management Committee (MMC) is responsible for maintaining this policy The NUH Medicines Safety Group (MSG) is responsible for overseeing the Trust wide risk assessment on wrong route administration of oral medicines, feeds and flushes and informing MMC of any revision to this policy to mitigate new risks identified, or due to changes in national guidance or legislation. 5.2 Individual Officers The Clinical Procurement Matron working with Ward and Clinical Managers is responsible for ensuring that the correct equipment is available in the Trust to support the implementation of this policy All health professionals involved in the prescribing, supply or administration of flushes, feeds or medication via the oral or enteral routes have a responsibility to adhere to this policy and associated procedures. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

9 6.0 Policy and/or Procedural Requirements 6.1 Equipment Requirements Purple ENFit compatible oral/enteral syringes must be used for measurement and administration of medicines via the oral and enteral routes, and for the administration of feeds and flushes via the enteral route ENFit compatible bottle adaptors or ENFit compatible Straws must be used with an ENFit compatible oral/enteral syringe to withdraw liquid medicines from medicine bottles Intravenous or parenteral (hypodermic) syringes must never be used for the purpose of administering liquid medicines, feeds or flushes via the oral and enteral routes (1) Intravenous 3-way taps must not be used for enteral feeding Systems (1) Adaptors which enable oral/enteral syringes to fit intravenous ports must not be used (1) Enteral feeding tubes and enteral feed administration and extension sets used at NUH must not contain any ports that can be connected to intravenous syringes or have end connectors that can be connected to intravenous or other parenteral lines (1). All enteral tubes and enteral equipment must have an ENFit end that connects to an ENFit enteral syringe only. During the transition to ENFit enteral feeding tubes, adaptors must be used for any patients who have not yet had their existing enteral feeding tube replaced. The exception to this is the use of Foley or Malecot urinary catheters which may be used as a gastrostomy tube in neonates and children. In these patients an enteral male adaptor must be connected to the urinary catheter to enable use of an oral / enteral syringe. 6.2 Labelling requirements Enteral feed administration sets and syringes used in NUH must be clearly labelled enteral. (1) The ward nurse must label the feed administration set with an ENTERAL label each time the feed administration set is changed. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

10 6.3 Administration Process Medication prescribed for patients with enteral feeding tubes must be rationalised to the least number of administration episodes possible without compromising patient care The process of preparation and administration of medication via the oral or enteral route must be separated in time from the process of preparation and administration of medication via the parenteral route i.e. intravenous, subcutaneous, intramuscular For inpatients, ENFit oral/enteral syringes used for oral administration or measuring liquid medicines for enteral administration must be single use only (4, 5). i.e. use for one drug for one patient for one administration episode and dispose of immediately. However one large ENFit enteral syringe can be used for a set of enteral administrations during a single patient episode of care. i.e. can be re-used for the same patient during a set of drug or feed administrations & flushes at a given administration time. The enteral syringe must be disposed of immediately after the set of drug or feed administrations are complete Medication drawn up into oral/enteral syringes must be administered immediately The nurse who prepares the medication must be the nurse who administers the medication to the patient All used oral and enteral syringes must be treated as pharmaceutically contaminated waste and disposed of according to the Trust waste handling and management policy HS/EI/ Self-administration As stated in the NUH Medicines Policy CL/MM/005 Selfadministration of medicines by patients, parents or carers policy, a patient or carer may administer medicines where selfadministration procedures are in place and where they have been assessed as competent by a nurse. On children s wards patients and carers may participate in medicine administration where the ward staff consider them competent to do so. A parent or carer may administer feeds or flushes via the enteral route once they have been taught the procedure and assessed competent by a trained nurse. A competency tick list will be completed as proof of competence and a copy stored in the child s The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

11 medical notes. 6.5 Legislation /National Guidance The Medicines Act 1968 governs the supply and administration of all medicines in the UK. The majority of medicines prescribed in the UK are licensed under this Act. To remain licensed the medicine must be given in a licensed form, within a licensed dose range, by a licensed route and only for conditions where the manufacturer has tested the medicine for safety. The administration of medication via enteral feeding tubes is likely to be outside of the licensed indications and route of administration included in the product s Summary of Product Characteristics (6). The dispersing and crushing of tablets and opening of capsules will also place the medicine outside of its product licence (7). Under an exemption within the Medicines Act, Medical Practitioners (doctors and dentists) and Independent Prescribers may use licensed medicines for indications, doses or routes outside of the terms of the product licence (6, 7). In addition the regulations permit these medicines so prescribed to be dispensed by pharmacists and administered by nurses and midwives. Refer to Trust Policy for the Procurement and Use of Medicines without UK Marketing Authorisation and Medicines Used Outside of their UK Marketing Authorisation (CL/MM/010) (7). 7.0 Training and Implementation 7.1 Training This is an established policy however the change to the new ENFit equipment will require training. Nursing The Adult Nutrition Nurse Specialist will deliver a training session at the adult nutrition link nurse meetings for both campuses. Training will be provided via the Paediatric nutrition link nurses. The Ward Manager will be responsible for ensuring the training of all The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

12 staff on their ward involved in the administration of medicines feeds and flushes via the enteral route. The Ward Manager must keep a record of staff training and copy to the individual members of staff for their own records. The Ward Manager is responsible for identifying any gaps in training for their staff and facilitating further training through the Nutrition link Nurse for their area. Pharmacy The Lead Pharmacist for Paediatrics and Digestive Diseases & Thoracics Lead Pharmacist will provide training for Pharmacy staff. Dietetics Senior Dietitians will provide training sessions for Dietetic staff on the issues covered in this policy and keep a record of these activities. Dietitians will be responsible for providing compliant equipment for home discharge. 7.2 Implementation The Clinical Procurement Team will ensure ENFit compatible equipment is available on all wards and departments prior to implementation of this policy. Ward Managers are responsible for maintaining adequate stocks of ENFit compatible enteral syringes and ENFit bottle adaptors on their ward through liaison with clinical procurement or the material management assistant for their area. Training for relevant professional groups will be delivered in advance of the implementation of the policy. NUH COMMS will be used to communicate the new equipment and change in procedures. Divisional Governance Leads are responsible for distributing and implementing this policy within their Division. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

13 The Medicines Safety Group will manage the risk assessment for wrong route administration of oral medicines, feeds and flushes and will facilitate audit of adherence to this policy. 7.3 Resources Enteral syringes and bottle adaptors and straws are already in use across the Trust. The design of the equipment is changing to ENFit. There may be an increase in use of equipment due to the requirement to use an enteral syringe/bottle adaptor system for the measurement of all liquid medicines. This policy will require delivery of training via Nutrition Link Nurse meetings. 8.0 Trust Impact Assessments 8.1 Equality Impact Assessment An equality impact assessment has been undertaken on this draft and has not indicated that any additional considerations are necessary. 8.2 Environmental Impact Assessment An environmental impact assessment has been undertaken on this draft and has not indicated that any additional considerations are necessary. 8.3 Here For You Assessment A Here For You assessment has been undertaken on this draft and has not indicated that any additional considerations are necessary. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

14 9.0 Policy / Procedure Monitoring Matrix Minimum requirement to be monitored Trustwide risk assessment on wrong route administration of oral liquids, feeds and flushes Trustwide risk assessment on wrong route administration of oral liquids, feeds and flushes Responsible individual/ group/ committee Medicines Safety Group Nursing Pharmacy Dietetics Process for monitoring e.g. audit Review of incidents and review of risk assessment Frequency of monitoring as incidents arise and as part of Trustwide biannual incident review. Annual formal review of risk assessment Responsible individual/ group/ committee for review of results Medicines Safety Group reporting to Medicines Governance Committee Audit of policy annual Medicines Safety Group Responsible individual/ group/ committee for development of action plan Medicines Safety Group for Trust wide actions, Divisional Governance Groups for local actions Divisional Governance Groups for local actions Responsible individual/ group/ committee for monitoring of action plan Medicines Safety Group Medicines Safety Group The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

15 Divisional risk assessment on wrong route administration of oral liquids, feeds and flushes Divisional Governance Group Review of incidents and review of risk assessment At least annual Divisional Governance Group & share results with Medicines Safety Group. Divisional Governance Group Divisional Governance Group The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

16 10.0 Relevant Legislation, National Guidance and Associated NUH Documents Legislation: N/A 2. National Guidance: NPSA alert 2007, Promoting safer measurement and administration of liquid medicines via oral and other enteral routes, 28 th March 2007 NHS England Revised Never Events Policy and Framework, March Associated NUH Documents: NUH Medicines Policy CL/MM/005 Self-administration of medicines by patients, parents or carers policy NUH Medicines Policy CL/MM/010 for the Procurement and Use of Medicines without UK Marketing Authorisation and Medicines Used Outside of their UK Marketing Authorisation NUH Medicines Policy CL/MM/008- Drug administration Procedure for administration of medicines- paediatrics Procedure for the use of oral / enteral syringes to administer liquid medicines or feeds via the ORAL/ENTERAL ROUTE in children/ young people and neonates Procedure for the use of ENFit enteral syringes to administer liquid medicines via the ORAL route IN ADULTS Procedure for the use of syringes to measure and administer feeds, flushes and liquid medicines via the ENTERAL route IN ADULTS Working In New Ways Expanding The Scope Of Professional Practice Passing Fine Bore Nasogastric Tubes (For Adults And Paediatrics) Version 4 March 2012 NUH Guideline Enteral Feeding in adults The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

17 11.0 References 1. NPSA alert 2007, Promoting safer measurement and administration of liquid medicines via oral and other enteral routes, 28th March NHS England Revised Never Events Policy and Framework, March NUH Serious Incident investigations NUHWEB and NUHWEB Advice from NUH Infection Control Team (original policy CL/CGP/016 and CL/CGP/069) 5. NUH Single Use Policy 6. The NEWT Guidelines for the administration of medication to patients with Enteral feeding tubes or swallowing difficulties, accessed 02/11/ NUH Medicines Policy for Procurement and Use of Medicines without UK Marketing Authorisation and Medicines Used Outside of their UK Marketing Authorisation CL/MM/010 The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

18 APPENDIX 1 Procedure for the use of ENFit enteral syringes to administer liquid medicines via the ORAL route IN ADULTS 1. Definition For the purpose of this procedure a liquid medicine for administration via the oral route will be termed an oral liquid medicine. Such products include: A commercially available liquid medicine formulation Soluble tablets A specially manufactured liquid medicine Tablets crushed and mixed in water Tablets dispersed in water Capsules opened and mixed in water Injections administered orally 2. Patient group This procedure applies to all adults receiving oral liquid medicine via the oral route. 3. Syringes All ENFit compatible enteral syringes for use with this policy and procedure must be sterile (1). An ENFit compatible enteral syringe must be used to administer oral liquids via the oral route. 3.1 When to use an ENFit compatible enteral syringe An ENFit compatible enteral syringe should be used for the measurement and administration of oral liquid medicine doses for: All adult patients even if the dose is a multiple of 5ml All controlled drug liquids for accuracy reasons (also see controlled drugs policy CL/MM/012) The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

19 There will be exceptions where an ENFit compatible enteral syringe can not be used to measure the liquid e.g. if a bottle adaptor can not fit on to the liquid bottle. In this case the dose can be measured by pouring the liquid medicine into a graduated medicine pot if it is a multiple of 5ml. If it is not a multiple of 5ml then the correct amount can be drawn up using an ENFit compatible Straw. 3.2 Selection of oral syringe ENFit compatible enteral syringes are available in a range of sizes. To maintain accuracy, the smallest syringe for measuring the dose must be used. Syringes supplied with oral liquid medicines by manufacturers must not be used because they may not be just oral syringes i.e. may be syringes with luer locks which could connect to an intravenous line. There are exceptions, notably ciclosporin liquid which is incompatible with standard oral syringes, and the Epistatus brand of midazolam buccal liquid. If in doubt, advice must be sought from a Pharmacist or Medicines Information. 3.3 Re-use of ENFit compatible enteral syringes Within the NUH premises, syringes must be single use only in line with the Trust s Single Use Policy. i.e. use for one drug for one patient for one administration episode and dispose of immediately. Under no circumstances should the syringe be washed and re-used within the hospital environment 4 Selection of water to mix with tablets /capsules 4.1 Type of water to use The type of water used will depend on the patient group. Table 1 Patient group Immunocompromised patients Recommended Water to use with medication (1) Sterile water should be considered for all immunocompromised patients The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

20 All other patients at NUH (see local protocols) Freshly drawn drinking tap water (This is different to tap water see section 4- Definitions) Sterile water should be taken from a bottle of Sterile water. A new bottle must be used for each episode of care (1). 4.2 Volume of water to use The volume of water used will depend on the individual patient and their fluid requirements. The volume of water used during administration of medicines must be recorded on the patient s fluid balance chart. If the volume of fluid is not a concern, a minimum of 10-15ml water should be used to disperse each tablet /mix with crushed tablet or powder from capsules (2). 5 Measurement of commercial and manufactured liquid medicine doses 5.1 Use of Bottle Adaptors with an ENFit compatible enteral syringe A sterile ENFit compatible bottle adaptor MUST be inserted into the neck of the medicine bottle when it is first opened. An ENFit compatible enteral syringe is the only syringe which will connect to the ENFit bottle adaptor. An ENFit enteral syringe should be used to measure all liquid medication. The ENFit compatible bottle adaptor must remain in situ whilst the medicine is in regular use. If it falls onto the floor or is removed for any other reason it must be disposed of and replaced with a new one. Bottle adaptors are single use and must not be washed and re-used. An ENFit compatible bottle adaptor will be supplied from inpatient pharmacy with all non-stock liquid medication. The nurse responsible for that patient will be responsible for inserting the bottle adaptor into the liquid medication upon first opening. Stock bottles of liquid medication which is dispensed from pharmacy stores will not have a bottle adaptor supplied with it. The nurse opening the stock The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

21 liquid medication for the first time will be responsible for inserting the ENFit compatible bottle adaptor into the bottle. ENFit compatible bottle adaptors of various sizes will be available on the ward. All controlled drug liquids MUST have an ENFit compatible bottle adaptor inserted for accurate measurement Measurement of doses using an ENFit compatible bottle adaptor Select the oral liquid medicine to be administered. Shake the bottle if necessary. Insert an ENFit compatible bottle adaptor if it does not already have one in place. Insert the ENFit compatible syringe into the ENFit compatible bottle adaptor. Invert the bottle and withdraw the required volume for the dose prescribed. Multiple drugs must not be withdrawn into the same syringe. The original cap of the liquid medication should be replaced with the bottle adaptor in situ. 5.2 Straws Straws must only be used when the neck of the medicine bottle is too large/small for the bottle adaptor to fit. Straws are single use only and must not be left in the bottle or washed and re-used Measurement of doses using an ENFit compatible Straw Select the oral liquid medicine to be administered. Shake the bottle if necessary. Attach an ENFit compatible syringe onto the end of the ENFit compatible straw. Insert ENFit compatible straw into the bottle The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

22 Withdraw the required volume for the dose prescribed. Dispose of the ENFit compatible straw and replace the lid on the bottle. 6. Preparation of drugs which are not commercially available as an oral liquid formulation If a patient is unable to swallow the medication they are prescribed as a tablet or capsule, due to their age or swallowing difficulties, then the Ward Pharmacist or Medicines Information department must be contacted for advice. The alteration of medical formulations e.g. crushing tablets or opening capsules is outside of the product licence of the drug (3) and may alter the patients handling of the drug. Some drugs are not suitable for crushing. (Table 2) Table 2 Formulation /class of drug Enteric coated tablets (EC) Modified release (MR) /Sustained release (SR) Possible problem from crushing tablets The coating may protect the stomach from damage from the drug e.g. aspirin, and may cause gastrointestinal side effects. The coating may protect the drug from the acid in the stomach. (3) Crushing these drugs may result in abrupt high or low peaks of the drug which can be dangerous to the patient, especially if the drug has a narrow therapeutic range (3) Chewable tablets Designed to be partially absorbed in the mouth, not all the drug will be absorbed if they are crushed (3) The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

23 Cytotoxics & hormones Potential risk of toxicity to the staff handling the drug (3) The pharmacist must review the patient s prescription and discuss with the Prescriber whether alternative licensed liquid medicine formulations are available within the same class of drug or whether the drug prescribed could be given by an alternative route. Alternative routes of administration include: Rectal route Transdermal route Buccal route Sublingual route Parenteral route (intravenous, subcutaneous, intramuscular) If a licensed preparation or route is not available or appropriate for the patient, then the pharmacist may recommend crushing or dispersing tablets, opening capsules or manufacturing a suspension for the individual patient. This should be endorsed onto the drug chart. 6.1 Dispersing tablets in water It is not necessary to use an oral syringe. Place the tablet(s) into a medicine pot of water. Wait for the tablet to disperse / effervescent reaction to be complete. This may take a few minutes. Give the patient the solution to drink. Rinse the medicine pot with more water and give this to the patient to drink. 6.2 Crushing tablets A ceramic pestle and mortar or tablet crusher must be used. Place the required tablet(s) in the mortar or tablet crusher and crush to a powder. Mix the powder with an appropriate volume of water in a medicine pot (see section 4). Draw up the solution into an oral syringe. Administer the dose to the patient (see section 7) Rinse out the mortar / tablet crusher with water and administer the rinsings to the patient. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

24 The pestle and mortar or tablet crusher must be cleaned thoroughly with a detergent and water after each use and dried thoroughly using a paper towel. 6.3 Opening capsules Open the capsule and tip the powder into a medicine pot. Mix the powder with an appropriate volume of water (see section 4). Draw up the solution into an ENFit compatible enteral syringe. Administer the solution to the patient (see section 7). Rinse the medicine pot and administer the rinsings to the patient. 6.4 Cytotoxics A ready-made liquid should be used wherever possible. Ask pharmacy for advice. For cytotoxic drugs the ENFit compatible syringe must be disposed of in a cytotoxic waste disposal container. 6.5 Preparation of injections for oral use Consult pharmacy for advice on which injectable preparations are suitable for oral/enteral administration and directions for preparation. If not already in solution, reconstitute the injection following the manufacturer s information or directions from pharmacy as appropriate. Draw up the required dose using an ENFit compatible syringe connected to an: o ENFit compatible blunt needle for vials o ENFit compatible filter straw for glass ampoules Remove ENFit compatible needle or ENFit compatible straw before administration Vancomycin Vancomycin injection is licensed for administration via the oral route for the treatment of Clostridium difficile. The injection must be reconstituted following the manufacturer s information using the method described in 6.4. Remove ENFit compatible needle before administration. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

25 7 Administration of oral liquid medicines Check the inpatient prescription chart. Select the appropriate size ENFit compatible enteral syringes for the doses prescribed. Use the methods described in section 5 and 6 to prepare the oral liquid medicine doses. Prepare and administer one drug at a time. Complete the usual drug administration checks in the NUH Medicines Code of Practice. Insert the ENFit compatible enteral syringe into the inside of the patient s cheek and slowly depress the plunger asking the patient to swallow as is comfortable for them. Dispose of the used syringe into a sharps container as per the Trust policy for disposal of pharmaceutically contaminated products. Sign the inpatient medication chart to record administration of the drug immediately after it has been given. Repeat the above steps for each medication prescribed. The nurse who prepares the medication must be the nurse who administers the medication to the patient. If the administration process is interrupted at the point of administration, and medication has been left unattended drawn up in an unlabelled oral syringe, then the medication must be discarded. If there is any doubt over which medication has been administered, then the doctor must be informed immediately and a decision made whether to omit the medication until the next administration time. If the patient finds it difficult or uncomfortable to take the medication via the syringe then it can be transferred into a medicine pot and given to the patient to drink. Smaller doses may need diluting with water. If necessary seek advice from pharmacy. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

26 8 Discharge & Outpatient supply of medication For all adults prescribed oral liquid medicines via the oral route on discharge or as an outpatient, Pharmacy will supply one multi-use ENFit compatible syringe for each newly supplied oral liquid medication and an ENFit compatible bottle adaptor. Syringe size will be appropriate to the volume of medication required. 9 Responsibilities Ward managers are responsible for maintaining adequate stocks of ENFit compatible syringes, ENFit compatible bottle adaptors, ENFit compatible Straws and ENFit compatible blunt needles on their ward through liaison with the Clinical Procurement team. Senior Managers (Pharmacists, Dietitians, Nurses, Prescribers) are responsible for ensuring that all their staff are aware of this procedure and comply with it. 10. References 1. Advice from NUH Infection Control Team (original policies CL/CGP/016 and CL/CGP/069 now superseded- available from Medicine Management Committee) 2. BAPEN guideline: Administering Drugs via Enteral Feeding Tubes. A Practical Guide published 2003 updated Accessed 02/11/ The NEWT Guidelines for the administration of medication to patients with Enteral feeding tubes or swallowing difficulties, accessed 02/11/2016 The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

27 APPENDIX 2 Procedure for the use of ENFit compatible syringes to measure and administer feeds, flushes and liquid medicines via the Enteral route IN ADULTS 1. Unlicensed route of administration Administration of medication via the enteral route is usually unlicensed. The prescriber and practitioner accept liability for any adverse effects resulting from this route of administration (1). Refer to NUH Medicines Policy for Procurement and Use of Medicines without UK Marketing Authorisation and Medicines Used Outside of their UK Marketing Authorisation CL/MM/010. If the prescription does not clearly specify the route as enteral, the drugs must not be administered until the prescriber has been contacted and confirmed the route. 2. Definition For the purpose of this procedure an oral liquid medicine is one which is intended to be administered normally via the mouth but for clinical reasons needs to be administered via the enteral route. Such products include: A commercially available liquid medicine formulation Soluble tablets A specially manufactured liquid medicine Tablets crushed and mixed in water Tablets dispersed in water Capsules opened and mixed in water Injections administered orally 3. Patient group This procedure applies to all adults receiving oral liquid medication, feeds or flushes via the enteral route. 4. Syringes 4.1 Selection of ENFit compatible enteral syringe for administration via enteral tube or enteral feed administration set If an enteral feed administration set is in use at the time medication is due then the medication must be administered via the medicines administration The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

28 port. The enteral feed administration set must not be disconnected to allow administration directly into the enteral tube and then reconnected. There are different sizes of ENFit compatible enteral syringes available. All Enteral compatible syringes supplied for this purpose are sterile. Only purple 60ml ENFit compatible enteral syringes marked ENTERAL must be used for the administration of medication, feeds or flushes via the enteral route. Parenteral (Intravenous), syringes must never be used. 4.2 Selection of ENFit compatible enteral syringe to measure drug doses All ENFit compatible enteral syringes for use with this policy and procedure must be sterile (2). ENFit compatible enteral syringes are available in a range of sizes. To maintain accuracy, the smallest syringe for measuring the dose must be used. Syringes supplied with oral liquid medicines by manufacturers must not be used because they may not be just oral syringes i.e. may be syringes with luer locks which could connect to an intravenous line. There are exceptions, notably ciclosporin liquid which is incompatible with standard oral syringes. If in doubt, advice must be sought from the Pharmacist or Medicines Information 4.3 Re-use of syringes Within the NUH premises, ENFit compatible enteral syringes for oral administration must be single use only (3) in line with the Trust s Single Use Policy. i.e. use for one drug for one patient for one administration episode and dispose of immediately Large ENFit compatible enteral syringes must be one syringe per patient episode of care. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

29 5 Water i.e. can be re-used for the same patient during a set of drug administrations & flushes at a given administration time. Each drug should be flushed through with water after it has been administered (see section 8).The syringe must be disposed of immediately after the set of drug administrations and flushes are complete. 5.1 Type of water to mix with tablets /capsules /flush enteral tubes The type of water used will depend on the patient group and type of enteral tube. Sterile water should be taken from a bottle of sterile water. A new bottle should be used for each patient episode of care (2). Table 1 Patient group Enteral Tube Recommended water for flushes /mixing with tablets or capsules (2) Immunocompromised patients Enteral tubes feeding into the stomach Sterile water should be considered for all immunocompromised patients at NUH (see local protocols) All other patients Enteral tubes feeding in to the jejunum Enteral tubes feeding in to the stomach Enteral tubes feeding in to the jejunum Sterile water Freshly drawn drinking tap water (this is different to tap water see section 4 definitions) Sterile water 5.2 Volume of water to use The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

30 The volume of water used will depend on the individual patient and their fluid requirements but should be sufficient to flush the drug out of the delivery system. The volume of water used during administration of medicines should be recorded on the patient s fluid balance chart Dispersing tablets or mixing with crushed tablets or opened capsules If the volume of fluid is not a concern, a minimum of 10-15ml water should be used to disperse each tablet / mix with crushed tablet or powder from capsules (1) Flushes Water should be used to flush the enteral feeding system. Follow instructions from the dietitian. 6 Measurement of commercial and manufactured liquid medicine doses 6.1 An ENFit compatible enteral syringe must be used to measure all controlled drug liquids and all liquid medication even if it is a multiples of 5ml. The dose must then be transferred into the barrel of a 60ml syringe prior to administration via the enteral route (see section 8) Use of Bottle Adaptors with an ENFit enteral syringe A sterile ENFit compatible bottle adaptor must be inserted into the neck of the medicine bottle when it is first opened. The bottle adaptor must remain in situ whilst the medicine is in regular use. If it falls onto the floor or is removed for any other reason it must be disposed of. Bottle adaptors must not be washed and re-used Measurement of doses using a bottle adaptor Select the oral liquid medicine to be administered. Shake the bottle if necessary. Insert an ENFit compatible bottle adaptor if it does not already have one in place. Insert the ENFit compatible syringe into the ENFit compatible bottle adaptor Invert the bottle and withdraw the required volume for the dose prescribed. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

31 Multiple drugs must not be withdrawn into the same syringe. The original cap of the liquid medication must be replaced with the bottle adaptor in situ Straws Straws must only be used when the neck of the medicine bottle is too large/small for the bottle adaptor to fit. Straws are single use only and must not be left in the bottle or washed and re-used Measurement of doses using an ENFit compatible Straw Select the oral liquid medicine to be administered. Shake the bottle if necessary. Attach an ENFit compatible syringe onto the end of the ENFit compatible straw. Insert ENFit compatible straw into the bottle Withdraw the required volume for the dose prescribed. Dispose of the ENFit compatible straw and replace the lid on the bottle. 6.2 Doses which are multiples of 5ml Doses which are a multiple of 5ml should be drawn up using an ENFit compatible enteral syringe for accuracy of measurement and transferred to a 60ml syringe. All Controlled Drugs MUST be measured using an ENFit enteral syringe Measurement of doses using a medicine pot and ENFit compatible enteral syringe A medicine pot should only be used if an ENFit compatible bottle adaptor can not fit on to the bottle neck of the liquid medication. Select the oral liquid medicine to be administered Shake the bottle if necessary Measure the dose required into a graduated medicine pot The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

32 Select the 60ml ENFit compatible syringe required for enteral administration Draw up the oral liquid medicine from the medicine pot into the enteral syringe and give as per section 8 Prepare and administer each drug as an individual process. Each drug should be flushed through with water after administration and the same enteral syringe may be re-used for administration of flushes and subsequent drugs required within the individual patient s episode of care. Liquid medication that is not a multiple of 5ml can be drawn up using a straw and correct size ENFit compatible enteral syringe and transferred to a 60ml syringe for enteral administration. 7 Preparation of oral drugs which are not commercially available as a liquid formulation The alteration of medical formulations for administration via enteral tubes e.g. crushing tablets or opening capsules, is usually outside of the product licence of the drug (1) and may alter the handling of the drug. Some drugs are not suitable for crushing. (Table 2) Table 2 Formulation /class of drug Enteric coated tablets (EC) Modified release (MR) /Sustained release (SR) Buccal /sublingual comments If crushed enteric coated tablets break up into small pieces that clump together when moistened and can clog the feeding tube (1) Crushing these drugs may result in abrupt high or low peaks of the drug which can be dangerous to the patient, especially if the drug has a narrow therapeutic range (1) Designed to avoid the GI tract and first pass metabolism. The doses tend to be low and maybe insufficient if given via an enteral tube (1) The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

33 Chewable tablets Cytotoxics & hormones Designed to be partially absorbed in the mouth, not all the drug will be absorbed if they are crushed (1) Potential risk to staff from aerolisation of particles (1) The pharmacist must review the patient s prescription and discuss with the Prescriber whether alternative licensed liquid medicine formulations are available within the same class of drug or whether the drug prescribed could be given by an alternative route. Alternative routes of administration include: Rectal route Transdermal route Buccal route Sublingual route Parenteral (intravenous, subcutaneous, intramuscular) If a licensed preparation or route is not available or appropriate for the patient, then the pharmacist may recommend crushing or dispersing tablets, opening capsules or manufacturing a suspension for the individual patient. 7.1 Dispersing tablets in water (4) Place the tablet in a medicine pot and disperse in 10mls of water Use a 60ml ENFit compatible enteral syringe to draw up the dispersed solution from the medicines pot Administer the solution Rinse the syringe with more water and administer the rinsings 7.2 Crushing tablets (4) A tablet crusher must be used Place the required tablet in the tablet crusher and crush to a powder. Mix the powder with an appropriate volume of water (see section 5). The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

34 Draw up the solution into a 60ml ENFit compatible enteral syringe Administer the dose to the patient (see section 8) Rinse out the tablet crusher with water, draw up into the ENFit compatible enteral syringe and administer this to the patient The tablet crusher must be cleaned thoroughly with a detergent and water after each use and dried thoroughly using a paper towel. 7.3 Opening capsules(4) Open the capsule and tip the powder into a medicine pot Mix the powder with an appropriate volume of water (see section 5) Draw up the solution into a 60ml ENFit compatible enteral syringe Administer the solution to the patient (see section 8 ) Rinse the medicine pot, draw up into the ENFit compatible enteral syringe and administer this to the patient. 7.4 Cytotoxics A ready-made liquid should be used wherever possible. Ask pharmacy for advice. For cytotoxic drugs the ENFit compatible syringe must be disposed of in a cytotoxic waste disposal container. 7.5 Preparation of injections for enteral administration consult pharmacy for advice on which injectable preparations are suitable for oral/enteral administration and directions for preparation. If not already in solution, reconstitute the injection following the manufacturer s information or directions from pharmacy as appropriate. Draw up the required dose using an ENFit compatible syringe connected to a: ENFit compatible blunt needle for vials ENFit compatible filter straw for glass ampoules The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

35 Remove ENFit compatible needle or ENFit compatible straw before administration Vancomycin Vancomycin injection is licensed for administration via the oral route for the treatment of Clostridium difficile. The injection must be reconstituted following the manufacturer s information using the method described in 7.4. Remove ENFit compatible needle before administration The solution must be administered to the patient (see section 8) 8 Administration of oral liquid medicine formulations via the enteral route Review the inpatient prescription chart to identify the drugs and doses to be administered via the enteral route for this administration episode. Select the appropriate type of 60ml ENFit compatible enteral syringe for administration of the oral liquid medicine to the patient (section 4 and Appendix 1) Select the appropriate type of water for the patient (section 5 Table 1) Proceed to the patient. Follow all the administration steps described in NUH medicines Code of Practice Check the patient s identity. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

36 Check the position of the enteral tube following the appropriate Nursing guideline for the type of enteral tube in place. Check the enteral tube or feed administration set back to the patient to confirm the route and check that the feed administration set is labelled enteral. Stop the feed if there is a feed in progress. Flush the enteral tube with an appropriate volume of water for the individual patient (see section 5). Prepare the first dose required using the methods described in section 6 & 7 If the dose has been prepared in a smaller ENFit compatible enteral syringe, the medication must be transferred to the 60ml enteral syringe before it can be administered. Attach the 60ml ENFit compatible enteral syringe to the enteral tube or enteral feed administration port as appropriate. Remove the plunger of the 60ml enteral syringe. Eject the contents of the liquid medication into the barrel of the 60ml ENFit compatible enteral syringe. If the medication has been dispersed in a medicine pot draw the contents in the pot into a 60ml enteral syringe. This should then be gravity fed to administer it to the patient if attached directly to the enteral tube, or using the plunger if administration is via the enteral feed administration set. Sign the inpatient medication chart to record administration of the drug immediately after it has been given. Repeat the above steps for each medication prescribed. The same ENFit compatible enteral syringe can be used throughout the patient episode of care. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

37 If more than one medicine is to be administered, the enteral tube must be flushed with at least 10ml water in between each medicine unless another volume is specified by the Dietitian. After the last medicine has been administered, the enteral tube must be flushed with 30ml water unless another volume is appropriate and specified by the Dietitian. Restart the feed, if it has been stopped. Dispose of the used syringe into a sharps container as per the Trust policy for disposal of pharmaceutically contaminated products. The nurse who prepares the medication must be the nurse who administers the medication to the patient. If the administration process is interrupted at the point of administration, and medication has been left unattended drawn up in an ENFit compatible enteral syringe, then the medication must be discarded. If there is any doubt over which medication has been administered then the doctor must be informed immediately and a decision made whether to omit the medication until the next administration time. 9 Administration of Bolus Enteral Feeds Bolus enteral feeds must be administered using a 60ml ENFit compatible enteral Syringe. Refer to the appropriate enteral feeding guideline. 10 Aspiration of Gastric Contents to check tube position ENFit compatible enteral syringes must be used for aspirating all enteral tubes. 11 Discharge Ward nursing staff are responsible for ensuring parents/carers can safely prepare and administer the medicines via the enteral tube prior to discharge. The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

38 Ward nursing staff are responsible for notifying the Dietitian and the Pharmacist in a timely fashion when the discharge is planned. The prescriber must specify the route of administration on the discharge prescription. For all adults prescribed oral liquid medicines via the enteral route on discharge or as an outpatient, Pharmacy will supply one multi-use ENFit compatible syringe for each newly supplied oral liquid medication and an ENFit compatible bottle adaptor. Syringe size will be appropriate to the volume of medication required. Dietitians will provide an appropriate supply of ENFit syringes for feeds at discharge for use in the community. Multi-use ENFit compatible syringes can be washed and re-used at home in accordance with the manufacturer s instructions. 12 Responsibilities Ward managers are responsible for maintaining adequate stocks of ENFit compatible syringes, ENFit compatible bottle adaptors, ENFit compatible Straws and ENFit compatible blunt needles on their ward through liaison with the Clinical Procurement team. Senior Managers (Pharmacists, Dietitians, Nurses, Prescribers) are responsible for ensuring that all their staff are aware of this procedure and comply with it. 10. References 1. The NEWT Guidelines for the administration of medication to patients with Enteral feeding tubes or swallowing difficulties, accessed 02/11/ Advice from NUH Infection Control Team (original policy CL/CGP/016 and CL/CGP/069) 3. NUH Single Use Policy 4. BAPEN guideline: Administering Drugs via Enteral Feeding Tubes. A Practical Guide published 2003 updated Accessed 02/11/2016 The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

39 BAPEN Administering Drugs via Enteral Feeding Tubes A Practical Guide ( The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

40 The use of syringes to administer flushes, feeds and medication via the oral and enteral routes policy CL/MM/037 version 1, November

#NPPG2016. ENFit syringes. Andrew Wignell, Paediatric Pharmacist, Nottingham University Hospitals

#NPPG2016. ENFit syringes. Andrew Wignell, Paediatric Pharmacist, Nottingham University Hospitals #NPPG2016 ENFit syringes Andrew Wignell, Paediatric Pharmacist, Nottingham University Hospitals ENFit Syringes Andrew Wignell andrew.wignell@nuh.nhs.uk Objectives Describe the background to the changes

More information

Date Issued Planned Review PGN No: Part of NTW(C)29 - Trust Standard for Assessment and Management of Physical Health Author/Designation

Date Issued Planned Review PGN No: Part of NTW(C)29 - Trust Standard for Assessment and Management of Physical Health Author/Designation Trust Standard for Assessment and Management of Physical Health Policy Practice Guidance Note Enteral Tube Care, Management and Feeding (Gastrostomy and Jejunostomy) V01 Date Issued Planned Review PGN

More information

Preparing and Administering Medications Using ENFit : Procedure for Inpatient Settings

Preparing and Administering Medications Using ENFit : Procedure for Inpatient Settings Preparing and Administering Medications Using ENFit : Procedure for Inpatient Settings Purpose of this procedure: Outline the preparation and administration of medication doses using the ENFit system.

More information

MEDICINA NEWSLETTER2010

MEDICINA NEWSLETTER2010 MEDICINA NEWSLETTER2010 NEW SAFER SYRINGE PUMP FOR ENTERAL FEEDING Medicina continues its lead in the development of safer enteral feeding equipment with the development of new enteral syringe drivers.

More information

INFECTION PREVENTION AND CONTROL POLICY AND PROCEDURES Sussex Partnership NHS Foundation Trust (The Trust)

INFECTION PREVENTION AND CONTROL POLICY AND PROCEDURES Sussex Partnership NHS Foundation Trust (The Trust) A member of: Association of UK University Hospitals INFECTION PREVENTION AND CONTROL POLICY AND PROCEDURES Sussex Partnership NHS Foundation Trust (The Trust) IPC17 SINGLE USE AND SINGLE PATIENT USE MEDICAL

More information

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale

Standard operating procedures for preparation and administration of intramuscular injections. No Action Rationale Standard operating procedures for preparation and administration of intramuscular injections Preparation Overview No Action Rationale 1 Collect and check all equipment 2 Check that the packaging of all

More information

Tube feeding with a nasogastric or nasojejunal tube

Tube feeding with a nasogastric or nasojejunal tube Tube feeding with a nasogastric or nasojejunal This factsheet tells you how to care for your feeding and how to take your feed and medications via your. Your dietitian needs to fill in parts of this factsheet.

More information

Division 1 Introduction to Advanced Prehospital Care

Division 1 Introduction to Advanced Prehospital Care Division 1 Introduction to Advanced Prehospital Care Chapter 7 Intravenous Access and Medication Administration Part 1 Principles and Routes of Medication Administration Topics Aseptic Technique Medication

More information

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 Medication Safety Patient Safety Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 1 The patient journey Admission Ward Transfer Ward stay Discharge Medication storage and supply

More information

The prescribing newsletter for GPs, nurses and pharmacists NHS Northamptonshire Failure to respond to first choice antibiotics

The prescribing newsletter for GPs, nurses and pharmacists NHS Northamptonshire Failure to respond to first choice antibiotics Tablet Press EXTRA The prescribing newsletter for GPs, nurses and pharmacists NHS Northamptonshire Failure to respond to first choice antibiotics March 2017 Use of Buccolam (buccal midazolam) for breakthrough

More information

NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST. Medicines Policy: Code of practice Complementary Therapy

NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST. Medicines Policy: Code of practice Complementary Therapy NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST Medicines Policy: Code of practice Complementary Therapy Reference CL/MM/07 Approving Body Senior Management Team Date Approved 9 February 208 Implementation Date

More information

THE FLOCARE RANGE OF ENTERAL FEEDING PUMPS, TUBES AND ACCESSORIES

THE FLOCARE RANGE OF ENTERAL FEEDING PUMPS, TUBES AND ACCESSORIES THE FLOCARE RANGE OF ENTERAL FEEDING PUMPS, TUBES AND ACCESSORIES Flocare Enteral Feeding Pumps and Giving Sets Flocare Infinity Pump and Giving Sets...6 Flocare 800 Pump and Giving Sets...10 Flocare

More information

Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always

Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always 1 3 4 5 6 7 8 9 10 Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always take appropriate Standard measures

More information

Western General Hospital Tubefeeding Group Radiologically Inserted Gastrostomy Protocol, October 2008

Western General Hospital Tubefeeding Group Radiologically Inserted Gastrostomy Protocol, October 2008 Lothian University Hospitals Division Western General Hospital Protocol for the Care of Radiologically Inserted Gastrostomy Tube 14 FG Medicina G Tube CARE OF PATIENT FOLLOWING TUBE INSERTION OBSERVATIONS

More information

Part 1 Principles and Routes of Medication Administration

Part 1 Principles and Routes of Medication Administration 1 Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration 2 Caution: Administering medications is business Always take appropriate Standard measures to reduce your

More information

Administering Rescue Medication into Children for Prolonged Seizures

Administering Rescue Medication into Children for Prolonged Seizures Standard Operating Procedure 10 (SOP 10) Administering Rescue Medication into Children for Prolonged Seizures Why we have a procedure? Black Country Partnership NHS Trust (hereafter referred to as the

More information

Medicines Q&As Q&A What are the therapeutic options for patients unable to take solid oral dosage forms?

Medicines Q&As Q&A What are the therapeutic options for patients unable to take solid oral dosage forms? Medicines Q&As Q&A 294.3 What are the therapeutic options for patients unable to take solid oral dosage forms? Prepared by UK Medicines Information (UKMi) pharmacists for NHS healthcare professionals Before

More information

Optimal nutrition in critically ill children

Optimal nutrition in critically ill children Optimal nutrition in critically ill children MODULE 4 Good safety practices required for nutritional therapy Developed by The Asia Pacific Middle East Consensus Working Group on Nutrition Therapy in the

More information

Freka Balloon Gastrostomy Feeding. CARE GUIDELINES For Patients & Carers

Freka Balloon Gastrostomy Feeding. CARE GUIDELINES For Patients & Carers Freka Balloon Gastrostomy Feeding CARE GUIDELINES For Patients & Carers Useful Contacts GP Hospital Dietitian Community Dietitian Nutrition Nurse District Nurse Nutrition Feed Company/Nurse Advisor Hospital

More information

Pfizer, BeneFIX R2 Recombinant Factor IX

Pfizer, BeneFIX R2 Recombinant Factor IX Pfizer, BeneFIX R2 Recombinant Factor IX BeneFIX, Recombinant Factor IX, is indicated for the prevention and control of bleeding episodes in people with hemophilia B (Christmas Disease). BeneFIX is also

More information

The Development of Guidelines for Caring for an Infant, Child, or Young Person who Requires Enteral Feeding

The Development of Guidelines for Caring for an Infant, Child, or Young Person who Requires Enteral Feeding The Development of Guidelines for Caring for an Infant, Child, or Young Person who Requires Enteral Feeding Gillian McCorkell Carmel O Kane Patricia Meehan WHSCT Enteral Feeding The provision of safe and

More information

PROCEDURE REFERENCE NUMBER SABP/EXECUTIVE BOARD/0017/PROCEDURE15 PROCEDURE NAME MEDICINES PROCEDURE 15: METHOTREXATE

PROCEDURE REFERENCE NUMBER SABP/EXECUTIVE BOARD/0017/PROCEDURE15 PROCEDURE NAME MEDICINES PROCEDURE 15: METHOTREXATE PROCEDURE REFERENCE NUMBER SABP/EXECUTIVE BOARD/0017/PROCEDURE15 PROCEDURE NAME MEDICINES PROCEDURE 15: METHOTREXATE BRIEF OUTLINE OF THIS PROCEDURE This procedure sets out the requirements for prescribing,

More information

North of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines

North of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines \ North of England Cancer Network Policies and Procedures Standards for the Safe Use of Oral Anticancer Medicines NECN Oral Anticancer medicine Policy version 1.6 Page 1 of 17 Issue Date: Feb 2017 Contents

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide For needle and needle-free systems This guide provides detailed instructions on the reconstitution, dilution, and storage of VELETRI. It is intended to be used after your

More information

E096. Essential Shared Care Agreement: Melatonin (Circadin ) in Children, adolescents and adults only with Learning Disability

E096. Essential Shared Care Agreement: Melatonin (Circadin ) in Children, adolescents and adults only with Learning Disability E096 Essential Shared Care Agreement: Melatonin (Circadin ) in Children, adolescents and adults only with Learning Disability Please complete the following details: Patient s name, address, date of birth,

More information

concentrate intravenous solution and other strong potassium solutions

concentrate intravenous solution and other strong potassium solutions Policy for the use of potassium chloride concentrate intravenous solution and other strong potassium solutions CLINICAL GUIDELINES ID TAG Policy for the use of potassium chloride Title: concentrate intravenous

More information

ADMINISTRATION OF INSULIN

ADMINISTRATION OF INSULIN STANDARD OPERATING PROCEDURE ADMINISTRATION OF INSULIN Issue History First issued April 2012 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote the safe administration

More information

USE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE

USE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE NHS Scotland Directors of Pharmacy and Scottish Association of Medical Directors USE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE CONSENSUS STATEMENT This consensus

More information

Gastrostomy Tube Feeding

Gastrostomy Tube Feeding Gastrostomy Tube Feeding A gastrostomy tube (g-tube) is a tube that enters through your abdomen and rests in your stomach. This tube is used for tube feeding formula, water, and medicine (instead of taking

More information

Procedure for the prescribing and administration of insulin

Procedure for the prescribing and administration of insulin Procedure for the prescribing and administration of insulin Author: Lilian Baxendale and Heather Beadle Designation: Clinical Governance Pharmacists Version: Version 3 Date: December 2016 Date Approved:

More information

ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME

ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME STANDARD OPERATING PROCEDURE ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME First Issued July 08 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote

More information

Patient Group Directions Policy

Patient Group Directions Policy Patient Group Directions Policy Category: Summary: Equality Analysis undertaken: Valid From: Date of Next Review: Approval Date/ Via: Distribution: Related Documents: Author(s): Further Information: This

More information

SINGLE USE MEDICAL DEVICES POLICY

SINGLE USE MEDICAL DEVICES POLICY SINGLE USE MEDICAL DEVICES POLICY First Issued by/date BWW /BKW March 2001 Issue Version Purpose of Issue/Description of Change Planned Review Date 2 Update May 2011 Named Responsible Officer:- Approved

More information

Good Practice Guidance on Covert Administration of Medication

Good Practice Guidance on Covert Administration of Medication Good Practice Guidance on Covert Administration of Medication This good practice guidance is intended to be used as a framework for care home managers and domiciliary care providers in drawing up their

More information

Document Details Guidance For The Use Of Emergency Rescue Medication for Children With Epilepsy (Administration Of Buccolam)

Document Details Guidance For The Use Of Emergency Rescue Medication for Children With Epilepsy (Administration Of Buccolam) Title Document Details Guidance For The Use Of Emergency Rescue Medication for Children With Epilepsy (Administration Of Buccolam) Trust Ref No 1861-31321 Local Ref (optional) Main points the document

More information

Preparation of TAMIFLU for Oral Suspension. Emergency Compounding of an Oral Suspension from TAMIFLU Capsules (Final Concentration 15 mg/ml)

Preparation of TAMIFLU for Oral Suspension. Emergency Compounding of an Oral Suspension from TAMIFLU Capsules (Final Concentration 15 mg/ml) Preparation of TAMIFLU for Oral Suspension It is recommended that TAMIFLU for Oral Suspension be constituted by the pharmacist prior to dispensing to the patient: 1. Tap the closed bottle several times

More information

HANG TIMES OF ENTERAL FEEDS AND INFUSION EQUIPMENT (PLASTICS) FOR INPATIENTS IN OLCHC GUIDELINE HTEFIEI V1

HANG TIMES OF ENTERAL FEEDS AND INFUSION EQUIPMENT (PLASTICS) FOR INPATIENTS IN OLCHC GUIDELINE HTEFIEI V1 HANG TIMES OF ENTERAL FEEDS AND INFUSION EQUIPMENT (PLASTICS) FOR INPATIENTS IN OLCHC GUIDELINE Version Number V1 Date of Issue September 2016 Reference Number Review Interval Approved By Name: Fionnuala

More information

Tube Feeding Using the Gravity Method

Tube Feeding Using the Gravity Method PATIENT & CAREGIVER EDUCATON Tube Feeding Using the Gravity Method This information will help teach you how to use the gravity method to feed yourself and take your medications through your percutaneous

More information

Good practice for drug calculations

Good practice for drug calculations Good practice for drug calculations A step-by-step guide for nurses, doctors and all other healthcare professionals Pharmacyservices 7048 Drug Cal Guide A6 Update_AW.indd 1 22/07/2014 09:55 2 Contents

More information

Gastrostomy ( PEG ) tubes and the ED

Gastrostomy ( PEG ) tubes and the ED Gastrostomy ( PEG ) tubes and the ED Percutaneous endoscopic gastrostomy (PEG) and radiology-inserted gastrostomy (RIG) have become the modality of choice for providing enteral access to patients who require

More information

PATIENT GROUP DIRECTION PROCEDURE

PATIENT GROUP DIRECTION PROCEDURE PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Nutrition support in adults: oral supplements, enteral and parenteral feeding.

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Nutrition support in adults: oral supplements, enteral and parenteral feeding. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Nutrition support in adults: oral supplements, enteral and parenteral feeding. 1.1 Short title Nutrition support 2 Background a) The National

More information

PATIENT SAFETY ALERT

PATIENT SAFETY ALERT PATIENT SAFETY ALERT PROBLEM: Research in UK and elsewhere has identified a risk to patients from errors occurring during intravenous administration of potassium solutions. Potassium chloride concentrate

More information

Network Guidance for Handling the Spillage of Cytotoxic and Anti-Cancer Drug

Network Guidance for Handling the Spillage of Cytotoxic and Anti-Cancer Drug Network Guidance for Handling the Spillage of Cytotoxic and Anti-Cancer Drug West Midlands Expert Advisory Group for Systemic Anti-Cancer Therapy (SACT) Page 1 of 8 West Midlands Clinical Networks and

More information

Patient Information Publications Warren Grant Magnuson Clinical Center National Institutes of Health

Patient Information Publications Warren Grant Magnuson Clinical Center National Institutes of Health Warren Grant Magnuson Clinical Center National Institutes of Health What is a subcutaneous injection? A subcutaneous injection is given in the fatty layer of tissue just under the skin. A subcutaneous

More information

Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG

Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG Introduction This procedure is intended to encourage good practice in the management of opioid transdermal

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide This guide provides detailed instruction on the reconstitution, dilution, and storage of Veletri (epoprostenol) for Injection. It is intended to be used after your healthcare

More information

Home enteral feeding

Home enteral feeding Home enteral feeding Item Type Article Authors Corrigan, Grainne Publisher Nursing in General Practice Journal Nursing in General Practice Download date 01/09/2018 00:39:10 Link to Item http://hdl.handle.net/10147/578880

More information

SAFEty. Medicina Intravenous safety systems

SAFEty. Medicina Intravenous safety systems SAFEty Medicina Intravenous safety systems There is significant evidence that safer products should be more widely used, but until now these alternatives have been significantly more expensive. SAFEty

More information

with ENFit compatible connectors Enteral Syringes & Accessories PRODUCT GUIDE & ORDER CODES

with ENFit compatible connectors Enteral Syringes & Accessories PRODUCT GUIDE & ORDER CODES with ENFit compatible connectors Enteral Syringes & Accessories PRODUCT GUIDE & ORDER CODES LD31603 WHAT IS ENFit? To further reduce the risk of enteral tube feeding misconnections and improve patient

More information

Essential Shared Care Agreement: Melatonin (Circadin, Bio-Melatonin)

Essential Shared Care Agreement: Melatonin (Circadin, Bio-Melatonin) Ref No: E056 Essential Shared Care Agreement: Melatonin (Circadin, Bio-Melatonin) Please complete the following details: Patient s name, address, date of birth, and either complete when the consultant

More information

NOTTINGHAM CHILDREN S HOSPITAL Nursing Guideline. P07 Care and Management of Children with a Totally Implantable Venous Access Device (Portacath).

NOTTINGHAM CHILDREN S HOSPITAL Nursing Guideline. P07 Care and Management of Children with a Totally Implantable Venous Access Device (Portacath). NOTTINGHAM CHILDREN S HOSPITAL Nursing Guideline P07 Care and Management of Children with a Totally Implantable Venous Access Device (Portacath). Introduction A Portacath is a central venous access device

More information

Tube Feeding With a Pump

Tube Feeding With a Pump PATIENT & CAREGIVER EDUCATON Tube Feeding With a Pump This information will help teach you how to use a pump to feed yourself and take your medications through your percutaneous endoscopic gastrostomy

More information

Education for Self Administration of Intravenous Therapy HOME IV THERAPY PICC. Portacath

Education for Self Administration of Intravenous Therapy HOME IV THERAPY PICC. Portacath HOME IV THERAPY PICC Portacath Who To contact Cardio-Respiratory Integrated Specialist Services (CRISS) Office hours 0800 1630 hours Ph: 364 0167 Weekends and after hours, phone Christchurch Hospital operator

More information

Education for self administration of intravenous therapy HOME IV THERAPY. 30 minute - Baxter Pump Tobramycin

Education for self administration of intravenous therapy HOME IV THERAPY. 30 minute - Baxter Pump Tobramycin HOME IV THERAPY Tobramycin Tobramycin Check the order on the drug chart This can change when the results from your blood test come through. Your doctor will change the order, if required. A copy of the

More information

Patient information leaflet. Royal Surrey County Hospital. NHS Foundation Trust. Parenteral Nutrition. Nutrition Support Team (NST)

Patient information leaflet. Royal Surrey County Hospital. NHS Foundation Trust. Parenteral Nutrition. Nutrition Support Team (NST) Patient information leaflet Royal Surrey County Hospital NHS Foundation Trust Parenteral Nutrition Nutrition Support Team (NST) This leaflet gives you information to help you understand what parenteral

More information

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the

More information

CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY

CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY Version 4.0 March 2016 Review date March 2018 Introduction It is the purpose of this policy to provide clear guidelines that

More information

This guideline describes the care required for a patient receiving a red blood cell transfusion whilst undergoing extra corporeal therapies.

This guideline describes the care required for a patient receiving a red blood cell transfusion whilst undergoing extra corporeal therapies. Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Guidelines for care of a patient receiving a red blood cell transfusion whilst undergoing extra corporeal therapies.

More information

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Assisting a Service User to use an Inhaler (Adult)

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Assisting a Service User to use an Inhaler (Adult) Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Assisting a Service User to use an Inhaler (Adult) CLINICAL GUIDELINES ID TAG Medicines Management Specific Title: Procedure: Assisting

More information

Medication and Dysphagia To crush or not to crush? Paresh Parmar Care of Elderly & Stroke Pharmacist Northwick Park Hospital

Medication and Dysphagia To crush or not to crush? Paresh Parmar Care of Elderly & Stroke Pharmacist Northwick Park Hospital Medication and Dysphagia To crush or not to crush? Paresh Parmar Care of Elderly & Stroke Pharmacist Northwick Park Hospital 2014 1 OBJECTIVES Role of the pharmacist s understanding of dysphagia To highlight

More information

ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Do not Do not YOUR KIT CONTAINS:

ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Do not Do not YOUR KIT CONTAINS: ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Read the Instructions for Use before you start using ALPROLIX and each time you get a refill. There may be new information.

More information

SAFE HANDLING OF VACCINES

SAFE HANDLING OF VACCINES STANDARD OPERATING PROCEDURE SAFE HANDLING OF VACCINES Issue History Issue Version One Purpose of Issue/Description of Change Planned Review Date To ensure vaccines are stored in accordance with manufacturers

More information

Nasogastric Tube Patient Passport

Nasogastric Tube Patient Passport Nutrition and Dietetics Department Nasogastric Tube Patient Passport Please bring this booklet with you for all tube changes Patient Information If you need this information in another format or language

More information

Buccal Midazolam For the treatment of prolonged epileptic seizures, clusters of epileptic seizures and status epilepticus.

Buccal Midazolam For the treatment of prolonged epileptic seizures, clusters of epileptic seizures and status epilepticus. Oxfordshire Clinical Commissioning Group, Oxford University Hospitals NHS Trust and Oxfordshire Health NHS Foundation Trust Shared Care Protocol and Information for GPs Buccal Midazolam For the treatment

More information

Package leaflet: Information for the user. GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon

Package leaflet: Information for the user. GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon Package leaflet: Information for the user GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon Read all of this leaflet carefully before you are given this injection because it

More information

HumaPen LUXURA HD INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE

HumaPen LUXURA HD INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE 1 HumaPen LUXURA HD INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. The color of your HumaPen

More information

Latex and Occupational Dermatitis Policy Incorporating Glove Selection

Latex and Occupational Dermatitis Policy Incorporating Glove Selection Latex and Occupational Dermatitis Policy Incorporating Glove Selection DOCUMENT CONTROL: Version: 3 Ratified by: Risk Management Sub Group Date ratified: 17 July 2013 Name of originator/author: Health

More information

IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM

IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM BACKGROUND IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM SUMMARY OF ASSESSMENT AND ITS FINDINGS Colistimethate sodium (colistin sulfomethate sodium) is licensed in the UK to be given

More information

A themed review of patient safety incidents involving anti-cancer medicines 1 November June 2008

A themed review of patient safety incidents involving anti-cancer medicines 1 November June 2008 A themed review of patient safety incidents involving anti-cancer medicines 1 November 2003 30 June 2008 October 2010 Executive Summary National Patient Safety Agency 2010. Copyright and other intellectual

More information

Policy for the safe use of oral methotrexate

Policy for the safe use of oral methotrexate Policy for the safe use of oral methotrexate Policy Checklist Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Does this meet criteria of a Policy? Staff side

More information

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges.

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. MS9662 MS9663 HumaPen LUXURA INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. Your HumaPen LUXURA

More information

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

More information

Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation

Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation Workshop on Paediatric Formulations For Assessors in National Regulatory Agencies

More information

Gastrostomy Tube Management

Gastrostomy Tube Management Gastrostomy Tube Management Information for School Nurse Services and School Health Services Disclaimer: The information in this pamphlet is for information purposes only. Please follow individual school

More information

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical

More information

NAP 3 Report and findings of the 3rd National Audit Project of the Royal College of Anaesthetists. Section 3. Appendices

NAP 3 Report and findings of the 3rd National Audit Project of the Royal College of Anaesthetists. Section 3. Appendices NAP 3 Section 3 Appendices 136 NAP 3 Appendix 1 NAP 3 Appendix 1: Wrong route administration Comment from the National Patient Safety Agency Developing and implementing devices with safe connectors Dr

More information

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges.

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. MS9673 HumaPen LUXURA HD INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. The colour of your HumaPen

More information

Policy for the safe administration of Insulin

Policy for the safe administration of Insulin Policy for the safe administration of Insulin This is a working document and any changes that become necessary to this policy must be Notified in writing to the Medicine Management Group via the Chief

More information

Long-Term Care Updates

Long-Term Care Updates Long-Term Care Updates May 2016 By Katee Miller, PharmD Candidate, Mohamed Jalloh, PharmD, & Zara Risoldi Cochrane, PharmD, MS, FASCP Introduction Enteral nutrition (EN) through a tube is the preferred

More information

Clinical Calculation 5 th Edition

Clinical Calculation 5 th Edition Clinical Calculation 5 th Edition Chapter 6 Calculation of Oral Medications Pages 40-54 Oral Medications Medications that are administered by mouth and absorbed via the gastrointestinal tract are known

More information

Instructions for Use NITYR (ni-tir) (nitisinone) tablets

Instructions for Use NITYR (ni-tir) (nitisinone) tablets Instructions for Use NITYR (ni-tir) (nitisinone) tablets Read this Instructions for Use before you start taking NITYR tablets using an oral syringe or mixed in applesauce, and each time you get a refill.

More information

Pharmaceutical risk management strategies for parenteral nutrition. J. Eastwood (UK)

Pharmaceutical risk management strategies for parenteral nutrition. J. Eastwood (UK) ESPEN Congress Leipzig 2013 Pharmaceutical Session Pharmaceutical risk management strategies for parenteral nutrition J. Eastwood (UK) Pharmaceutical risk management strategies for parenteral nutrition

More information

Patient Group Directions (PGDs)

Patient Group Directions (PGDs) Patient Group Directions (PGDs) Document level: Trustwide (TW) Code: MP2 Issue number: 4 Lead executive Authors details Type of document Target audience Document purpose Medical Director Senior Clinical

More information

Medicines Optimisation Strategy

Medicines Optimisation Strategy Clinical Reducing Dosing Errors with Opioid Medicines (Controlled Drug SOP): Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic

More information

Experience of paediatric formulations in Marketing Authorisatrion Applications

Experience of paediatric formulations in Marketing Authorisatrion Applications Experience of paediatric formulations in Marketing Authorisatrion Applications Elisabeth RICCHI Senior Quality Assessor 1 Overview of the presentation Formulation Measuring device Reconstitution packaging

More information

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE TITLE: ISSUED FOR: ADMINISTRATION OF A FEEDING (CONTINUOUS OR INTERMITTENT) OR MEDICATION VIA A GASTROSTOMY TUBE-ADULT Nursing DATE: REVIEWED: PAGES: 07/82

More information

Guidelines and Standing Operating Procedures Administration of Buccal Midazolam to adults who have prolonged epilepsy seizures

Guidelines and Standing Operating Procedures Administration of Buccal Midazolam to adults who have prolonged epilepsy seizures Guidelines and Standing Operating Procedures Administration of to adults who have prolonged epilepsy seizures 2015 Guidelines and SOPs for the Administration of for Adults - final (2).doc Type i.e. Strategy,

More information

INNOVATIVE PRODUCTS G, J AND GJ-TUBES WITH ENFit TM CONNECTION

INNOVATIVE PRODUCTS G, J AND GJ-TUBES WITH ENFit TM CONNECTION MIC * & MIC-KEY * Enterostomy Tubes INNOVATIVE PRODUCTS G, J AND GJ-TUBES WITH ENFit TM CONNECTION DIGESTIVE HEALTH PRODUCT CATALOGUE INNOVATIVE PRODUCTS - G, J AND GJ-TUBES WITH ENFit TM CONNECTION DIGESTIVE

More information

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human) PATIENT / USER INFORMATION LEAFLET Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human) Read all of this leaflet carefully before you start taking this medicine. Keep this

More information

Central venous access devices for children with lysosomal storage disorders

Central venous access devices for children with lysosomal storage disorders Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Central venous access devices for children with lysosomal storage disorders This information explains about central

More information

Guidelines and Standing Operating Procedures Administration of Buccal Midazolam to children who have prolonged epilepsy seizures

Guidelines and Standing Operating Procedures Administration of Buccal Midazolam to children who have prolonged epilepsy seizures Guidelines and Standing Operating Procedures Administration of to children who have prolonged epilepsy seizures 2015 Guidelines and SOPs for the Administration of for Children - final.doc Type i.e. Strategy,

More information

MELATONIN Insomnia and Sleep Disorders in Children

MELATONIN Insomnia and Sleep Disorders in Children DOCUMENT TO BE SCANNED INTO ELECTRONIC RECORDS AS AND FILED IN NOTES Patient Name : Date of Birth: NHS No: Name of Referring Consultant: Contact number: INTRODUCTION Melatonin is a pineal hormone which

More information

HumaPen SAVVIO INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE

HumaPen SAVVIO INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE HumaPen SAVVIO INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE For Single Patient Use Only www.lilly.ca INTRODUCTION HumaPen SAVVIO is designed for ease of use. You can give yourself multiple doses from one

More information

BAYER: KOGENATE FS WITH BIOSET (Recombinant FVIII)

BAYER: KOGENATE FS WITH BIOSET (Recombinant FVIII) BAYER: KOGENATE FS WITH BIOSET (Recombinant FVIII) KOGENATE FS, Recombinant Antihemophilic Factor, is indicated for the prevention and control of bleeding episodes in people with hemophilia A (classical

More information

SELF-INJECTION GUIDE

SELF-INJECTION GUIDE SELF-INJECTION GUIDE (asfotase alfa) 40 mg/ml solution for injection 18 mg/0.45 ml 28 mg/0.7 ml 40 mg/1 ml 100 mg/ml solution for injection 80 mg/0.8 ml asfotase alfa Introduction Contents This Self-Injection

More information

Healthcare (clinical) Waste Awareness

Healthcare (clinical) Waste Awareness Healthcare (clinical) Waste Awareness Disposal of Dental Service Waste Dental services in NHS Boards, where applicable, can now use the healthcare (clinical) waste service provided by the NHS Board for

More information

Contributes to CQC Outcome number: 9&12 Consulted With Post/Committee/Group Date. Pharmacist. Alison Felton Head of Pharmacy/Deputy Chief.

Contributes to CQC Outcome number: 9&12 Consulted With Post/Committee/Group Date. Pharmacist. Alison Felton Head of Pharmacy/Deputy Chief. Prescribing paracetamol in adult inpatients at MEHT Type: Clinical Guideline Register No: 18005 Status: Public on ratification Developed in response to: In line with Basildon Contributes to CQC Outcome

More information

Saline (0.9%) Nebuliser Guideline

Saline (0.9%) Nebuliser Guideline Saline (0.9%) Nebuliser Guideline Full Title of Guideline: Author (include email and role): Division & Speciality: Version: 3 Ratified by: Scope (Target audience, state if Trust wide): Review date (when

More information

Draft Guidance for Pharmacists on Extemporaneous Dispensing. Version 1

Draft Guidance for Pharmacists on Extemporaneous Dispensing. Version 1 1. Introduction Draft Guidance for Pharmacists on Extemporaneous Dispensing Version 1 The purpose of this guidance is to assist pharmacists in discharging their legal and professional obligations to patients

More information